Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Laurence Marsteller, MD
AddedMar 31, 2024
UpdatedMay 31, 2026
Laurence Marsteller, MD

Laurence Marsteller, MD

Founder, Salutaris Medical Devices

CrunchbaseLinkedIn

Laurence Marsteller, MD's Career

Salutaris Medical Devices
Salutaris Medical Devices

Tucson, AZ, US

Founder
Radiance Therapeutics
Radiance Therapeutics

Tucson, AZ, US

Founder & CEO· C-Suite · Management

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Laurence Marsteller, MD's Career

Salutaris Medical Devices
Salutaris Medical Devices
$7.5M62008Tucson, AZ, US
Founder

Leadership at Salutaris Medical Devices

George MimuraGeorge MimuraBoard Member
George M.George M.Board Member

Similar to Salutaris Medical Devices

LumiTheraLumiTheraPoulsbo, WA, USMedical Devicesest. 2013LumiTheraPoulsbo, WA, US · est. 2013

LumiThera, Inc.: Innovating non-invasive ocular devices for treating acute and chronic eye disorders.

$36.5M19
NeovistaNeovistaNewark, CA, USMedical Devicesest. 2002NeovistaNewark, CA, US · est. 2002

NeoVista Inc: Advancing wet AMD treatment through innovative medical technology development.

$156.9M14
Qlaris BioQlaris BioWellesley, MA, USTherapeuticsest. 2019Qlaris BioWellesley, MA, US · est. 2019

Therapeutics firm focusing on high-need areas in debilitating eye diseases.

$25M9
Iscience SurgicalIscience SurgicalMenlo Park, CA, USMedical Devicesest. 1999Iscience SurgicalMenlo Park, CA, US · est. 1999

iScience Interventional designs and manufactures innovative biomedical devices for site-specific ocular therapies.

$22M30
Radiance Therapeutics
Radiance Therapeutics
$7.2M302018Tucson, AZ, US
Founder & CEO· C-Suite · Management

Leadership at Radiance Therapeutics

Harry GeorgeHarry GeorgeBoard Member
Marc SandroffMarc SandroffBoard Member
Peng KhawPeng KhawBoard Member

Similar to Radiance Therapeutics

XRad TherapeuticsXRad TherapeuticsNew York City, NY, USMedical Solutionsest. 2016XRad TherapeuticsNew York City, NY, US · est. 2016

Cutting-edge biotech in NYC specializing in medical solutions.

$498.6k5
Perfuse TherapeuticsPerfuse TherapeuticsSan Francisco, CA, USTherapeuticsest. 2018Perfuse TherapeuticsSan Francisco, CA, US · est. 2018

Perfuse Therapeutics: A seed-stage firm innovating retinal disease treatment, starting with glaucoma.

$9M11
Radionetics OncologyRadionetics OncologySan Diego, CA, USRadiopharmaceuticalsest. 2021Radionetics OncologySan Diego, CA, US · est. 2021

Radionetics Oncology: Innovating novel radiotherapeutics for diverse oncology treatments.

$82.5M20
Raze TherapeuticsRaze TherapeuticsCambridge, MA, USCancer Treatmentsest. 2013Raze TherapeuticsCambridge, MA, US · est. 2013

Raze Therapeutics, Inc.: A biotech firm focused on discovering and developing cancer treatments.

$24M9

People Similar to Laurence Marsteller, MD

Nugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakWillix HalimWillix HalimCEO · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailBrian KimBrian KimCo-Founder · KakaoKim Beom-sooKim Beom-sooCo-Founder · KakaoNini William HinscheNini William HinscheCo-Founder · RadianceAaron SelverstonAaron SelverstonCo-Founder · OwlizedDouglas C. MacLellanDouglas C. MacLellanCEO · Radient PharmaceuticalsMichael MansouriMichael MansouriCEO · MeetMo.ioDoug BernauerDoug BernauerFounder · RadiantVictor IannelloVictor IannelloFounder & CEO · Synchrony Financial